Aveanna Healthcare Holdings Inc. (AVAH) vs MBX Biosciences, Inc. Common Stock (MBX)

A side-by-side comparison of Aveanna Healthcare Holdings Inc. and MBX Biosciences, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVAH vs MBX

growth of $100 · dividends reinvested · last 2y
AVAH +129.5% (+51.5%/yr)MBX +147.5% (+57.3%/yr)MBX compounded faster over this window
100200300Start $10020252026$229$248
AVAH MBX

AVAH vs MBX: by the numbers

  • •MBX is the larger company ($2.73B vs $2.69B market cap).
  • •AVAH is profitable (10.56% net margin) while MBX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAVAHMBX
P/E ratio9.80N/A
Forward P/E15.03N/A
P/S ratio1.04N/A
P/B ratio9.386.66
EV / EBITDA13.24N/A
FCF yield5.88%N/A

Profitability

MetricAVAHMBX
Gross margin31.95%0.00%
Operating margin11.12%0.00%
Net margin10.56%0.00%
ROE95.64%-25.47%
ROIC15.45%-28.60%

Growth (annualized)

MetricAVAHMBX
Revenue CAGR (5Y)9.65%N/A
FCF CAGR (5Y)58.99%N/A
Total return CAGR (5Y)9.75%N/A

Frequently asked

Is AVAH or MBX more profitable?
AVAH runs the higher net margin — AVAH at 10.56% versus MBX at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.